CNBG vaccine with 86% efficacy registered in Bahrain
作者:admin 2020-12-14
Photo: CNBG
Bahraini government has registered a COVID-19vaccine developed by Chinese producer CNBG after reviewing its phase 3 clinical trialdata that shows 86% efficacy rate, and 100% efficacy in preventing medium and severe symptoms.
目前有 0 条留言